GILD

Gilead Sciences, Inc. Press Releases

$85.14
*  
1.54
1.78%
Get GILD Alerts
*Delayed - data as of Feb. 5, 2016  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing

Gilead Sciences Announces Declaration of Q1 Cash Dividend and Increases to Shareholder Return Programs
2/2/2016 4:01:00 PM - Business Wire
▲1.06 % Price Change since this news event. The Volume Ratio is 1.42.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Gilead Sciences Announces Fourth Quarter and Full Year 2015 Financial Results
2/2/2016 4:00:00 PM - Business Wire
▲1.96 % Price Change since this news event. The Volume Ratio is 1.42.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Covered Call Alerts For Gilead Sciences, Chipotle Mexican Grill, Michael Kors, Valeant Pharmaceuticals and Sysco Corporation Released By InvestorsObserver
2/2/2016 9:31:00 AM - PR Newswire
▲1.62 % Price Change since this news event. The Volume Ratio is 1.06.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Gilead Announces Promotion of Katie Watson to Executive Vice President, Human Resources
2/1/2016 5:00:00 PM - Business Wire
▲1.30 % Price Change since this news event. The Volume Ratio is 0.99.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Coventry Resources Inc.: ASX Quarterly Report
2/1/2016 9:02:00 AM - Market Wire


European Medicines Agency Validates Gilead’s Type II Variation Application for Truvada® for Reducing the Risk of Sexually Acquired HIV
2/1/2016 9:02:00 AM - Business Wire
▲3.08 % Price Change since this news event. The Volume Ratio is 1.33.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Gilead’s John C. Martin, PhD to Assume Role of Executive Chairman of the Board; John F. Milligan, PhD to Be Appointed Chief Executive Officer and Director
1/29/2016 8:00:00 AM - Business Wire
▼-0.25 % Price Change since this news event. The Volume Ratio is 4.76.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Gilead Sciences to Release Fourth Quarter and Full Year 2015 Financial Results on Tuesday, February 2, 2016
1/26/2016 5:00:00 PM - Business Wire
▼-7.67 % Price Change since this news event. The Volume Ratio is 1.71.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Covered Call Alerts For NVIDIA, Keryx Biopharmaceuticals, Fitbit, Gilead Sciences and Chipotle Mexican Grill Released By InvestorsObserver
1/20/2016 9:31:00 AM - PR Newswire
▼-3.85 % Price Change since this news event. The Volume Ratio is 1.64.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Galapagos and Gilead Cleared by U.S. Federal Trade Commission to Close Global Partnership on Filgotinib
1/13/2016 1:30:00 AM - Business Wire
▼-12.49 % Price Change since this news event. The Volume Ratio is 1.29.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Gilead Submits New Drug Application to U.S. Food and Drug Administration for Tenofovir Alafenamide (TAF) for the Treatment of Chronic Hepatitis B
1/12/2016 8:30:00 AM - Business Wire
▼-12.68 % Price Change since this news event. The Volume Ratio is 0.9.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Gilead Sciences to Present at the 34th Annual J.P. Morgan Healthcare Conference on Monday, January 11
1/8/2016 4:00:00 PM - Business Wire
▼-11.73 % Price Change since this news event. The Volume Ratio is 0.69.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Covered Call Alerts For Gilead Sciences, Synaptics Incorporated, The Gap Incorporated, Fitbit and Chipotle Mexican Grill Released By InvestorsObserver
1/8/2016 9:31:00 AM - PR Newswire
▼-11.77 % Price Change since this news event. The Volume Ratio is 1.25.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Gilead Terminates Phase 2 Study of Simtuzumab in Patients With Idiopathic Pulmonary Fibrosis
1/5/2016 6:00:00 PM - Business Wire
▼-14.41 % Price Change since this news event. The Volume Ratio is 1.55.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Gilead Announces Top-Line Results From Two Phase 3 Studies Evaluating Tenofovir Alafenamide (TAF) for Patients With Chronic Hepatitis B Infection
1/5/2016 8:30:00 AM - Business Wire
▼-13.56 % Price Change since this news event. The Volume Ratio is 1.28.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Gilead Announces U.S. FDA Priority Review Designation for Sofosbuvir/Velpatasvir for Treatment of All Genotypes of Chronic Hepatitis C Infection
1/4/2016 4:30:00 PM - Business Wire
▼-13.32 % Price Change since this news event. The Volume Ratio is 1.28.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day










Phase 3 Results for Zydelig® With Bendamustine and Rituximab for Relapsed Chronic Lymphocytic Leukemia (CLL) Presented at American Society of Hematology Annual Meeting
12/8/2015 7:30:00 AM - Business Wire
▼-16.69 % Price Change since this news event. The Volume Ratio is 0.8.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day





Learn more by visiting our FAQ page